Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody Rituximab

By Schumann Tamara   Schmidt Enno   Booken Nina   Goerdt Sergij   Goebeler Matthias  

Acta Dermato-Venereologica, Vol. 89, Iss. 1, 2009-01 ,pp. : 101-102

Medical Journals Limited

Access to resources Recommend Favorite

Prolonged treatment with rituximab in patients with refractory pemphigus vulgaris

By Barrera Maria Victoria   Mendiola Maria Victoria   Bosch Ricardo Juan   Herrera Enrique  

Journal of Dermatological Treatment, Vol. 18, Iss. 5, 2007-01 ,pp. : 312-314

Informa Healthcare

Access to resources Recommend Favorite

Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody

By Soda R.   Costanzo A.   Cantonetti M.   Orlandi A.   Bianchi L.   Chimenti S.  

Acta Dermato-Venereologica, Vol. 81, Iss. 3, 2001-06 ,pp. : 207-208

Medical Journals Limited

Access to resources Recommend Favorite

Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

By Kluger Nicolas   Cartron Guillaume   Bessis Didier   Guillot Bernard   Girard Céline  

Acta Dermato-Venereologica, Vol. 90, Iss. 1, 2010-01 ,pp. : 99-100

Medical Journals Limited

Access to resources Recommend Favorite

Rituximab (anti-CD20) zur Behandlung von bullösen Autoimmundermatosen

By Kasperkiewicz M.   Zillikens D.  

Der Hautarzt, Vol. 58, Iss. 2, 2007-02 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite